Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician March 15, 2004	Substance Abuse Questions and answers on substance abuse.
American Family Physician April 1, 2003 David J. Mersy	Recognition of Alcohol and Substance Abuse Ten percent of the population abuses drugs or alcohol, and 20 percent of patients seen by family physicians have substance-abuse problems, excluding tobacco use. These patients can be identified by relying on regular screening or a high index of suspicion based on "red flags."
Managed Care June 2007 Lisa A. Higgins	Sobering Stats Invite Insurers To Fight Alcoholism Effectively Health plans may not be able to control problem drinking by their members. They can, however, affect the way their contracted providers approach the problem. And that may be what makes the difference.
Managed Care April 2005 Martin Sipkoff	Insurers Give Substance Abuse New Identity: It's a Disease After years of short shrift from payers and insurers, substance abuse services get renewed interest. Health Plans in particular are re-evaluating their approach.
Managed Care March 2008 John Carroll	Should Plans Pay Physicians To Switch Patients to Generics? The AMA calls it a kickback, but the industry sees it as just good practice to give doctors an incentive to get patients on equivalent generics
American Family Physician April 1, 2003	Substance Abuse--How To Recognize It Am I drinking too much?... Am I taking risks with alcohol or other mood-altering substances?... Has my drinking or drug use become a habit?... Is alcohol or drug use taking over my life?... Has drinking alcohol or using drugs become a problem for me?... etc.
American Family Physician December 15, 2000 Toni Lapp	ACOG Addresses Psychosocial Screening in Pregnant Women Recognizing the broad range of psychosocial issues that pregnant women face is an important step toward improving women's health and birth outcomes...
American Family Physician May 15, 2004 Mark H. Ebell	Routine Screening for Depression, Alcohol Problems, and Domestic Violence This guide is one in a series that offers evidence-based tools to assist family physicians in improving their decision-making at the point of care.
Managed Care July 2007	AMA: Patients Will Feel Cuts in Medicare Next year's proposed 10 percent cut in Medicare payments is serving as a rallying point for members of the American Medical Association, which says the cuts will make it difficult for physicians to accept new Medicare patients.
Pharmaceutical Executive April 1, 2011	Off-Label But On Point? Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help.
The Motley Fool February 25, 2010 Brian Orelli	An Untouched Market Waiting to Be Captured Unfilled prescriptions are a potential boon to drug companies.
The Motley Fool September 28, 2010 Brian Orelli	Don't Get Stuck! Invest in Needle-Free Drugs Here's how to make some money off society's general disdain for needles through next-generation drugs.
The Motley Fool September 30, 2010 Brian Orelli	Avoid This Multibillion-Dollar Market It's just too crowded, but there's no doubt that psychiatric drugs are big business for some drugmakers.
The Motley Fool November 30, 2010 Brian Orelli	A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist.
The Motley Fool November 20, 2008 Brian Orelli	Like Coupons, Only Better Companies that provide medical products and services and are lowering their costs should do well in this environment.
Pharmaceutical Executive September 1, 2006 Patrick Clinton	From the Editor: Undecided People are buying drugs, because companies are selling drugs. Interfere with the selling process, and people won't buy as many drugs.
The Motley Fool August 28, 2009 Brian Orelli	Your Doctor Is Killing You ... Financially What the doctor does has a big effect on how much health care costs.
Chemistry World November 18, 2010 Ned Stafford	New drug pricing rules in Germany The law was approved on 11 November and will take effect from 1 January as part of an effort to rein in exploding costs for Germany's massive public health insurance system.
The Motley Fool July 30, 2010 Brian Orelli	A Faster Pathway to Drug Approvals A thinktank called the Pacific Research Institute has proposed letting drugs approved by the European Medicines Authority onto the market in the U.S. before the Food and Drug Administration has approved the drugs.
Managed Care May 2006 John Carroll	Medicare Debates Fairness of Pay For Primary Care and Specialists A growing controversy in MedPAC and in physician organizations could spill over into how all health plans compensate doctors.
BusinessWeek June 17, 2009 Catherine Arnst	Why the AMA Will Likely Support Health-Care Reform Obama's plan might lower specialists' pay, but it would help primary-care doctors, save the industry billions, and please voters.
The Motley Fool July 15, 2010 Brian Orelli	The Blockbuster Drug Survives Another Body Blow Avandia is still standing.
Managed Care December 2007 John Carroll	How Doctors Are Paid Now, And Why It Has to Change Everyone knows about the perverse incentive of fee-for-service medicine, but that hasn't had much effect on its use.
Financial Advisor June 2010 Andrew Gluck	Advising Doctors As medical economics change for the worse, both physicians and their financial advisors are getting organized.
Managed Care April 2006 John Carroll	Some Specialist Societies Feel Left Out of AMA-CMS Deal on P4P Many physicians question the fairness of a deal between the American Medical Association and the government that give doctors a bonus when they follow certain rules.
Pharmaceutical Executive August 1, 2005 Lena Chow	Docs of Shanghai They're short on status, pay, and respect, but China's young doctors hold keys to the world's fastest growing pharmaceutical market.
American Journal of Nursing November 2008 Madeline A. Naegle	Screening for Alcohol Use and Misuse in Older Adults: Using the Short Michigan Alcoholism Screening Test--Geriatric Version The availability of accurate, easy-to-use screening tools to detect people in need of counseling can increase the number of older adults whose lives can be improved and even lengthened.
The Motley Fool March 31, 2011 Brian Orelli	Drug Warning Labels: The Good, Bad, and Ugly Once a drug is approved, investors can't fall asleep and ignore FDA announcements about drugs. They come in different varieties, but warnings tend to be of the bad and ugly variety more often than the good.
Pharmaceutical Executive November 1, 2005 Rubinstein & Galardi	Bustin' a CAP: The Competative Acquisition Program The new Competitive Acquisition Program for Medicare Part B drugs aims to align market forces with the distribution of drugs and biologics that doctors administer in their offices, but increasing bureaucracy is a major downside.
BusinessWeek January 21, 2010 John Carey	Making Personalized Medicine Pay Medco and other pharmacy benefit managers say future profits depend on matching drugs to patients based on their genes.
American Family Physician July 15, 2005 Carrie Morantz	Newsletter AMA, AAFP Act to Protect Patients' Access to Prescriptions... AHRQ Releases Updated Guide to Clinical Preventive Services... HHS Awards $80.5 Million in Grants to Reduce Infant Mortality Rates... etc.
The Motley Fool January 29, 2010 Brian Orelli	How to Make Billions of Dollars Without Really Trying Lackluster Alzheimer's drugs have been doing it for years.
Search Engine Watch February 20, 2011 Dean Stephens	Social Networks and Health: Bad Medicine? Social networks can be invaluable for helping consumers with health care decisions, as well as brand awareness for health practitioners, organizations, and treatments -- as long as it's done right.
American Family Physician July 1, 2000 Ted D. Epperly	Health Issues in Men: Part II. Common Psychosocial Disorders During screening examinations and, when appropriate, other health-related visits, family physicians should be alert for signs and symptoms of common psychosocial disorders in men. Health issues of concern include alcohol and substance abuse, domestic violence, midlife crisis and depression.
The Motley Fool December 4, 2007 Brian Orelli	An Early Gift to Drugmakers Drugmakers could be allowed to market for drugs' off-label indications.
Chemistry World August 23, 2012 Dean Baker	Monopoly money It is remarkable that the system of patent support for prescription drug research has not become more of a policy issue.
American Family Physician October 1, 2006 Mark B. Stephens	Preventive Health Counseling for Adolescents The key to providing relevant and useful preventive counseling for adolescent patients is developing the trust necessary to discuss the specific issues that impact this age group.
Fast Company Elizabeth Segran	Doctor Visits Are So 2014 For scrappy startups, going up against the health care system sometimes seems like an impossible task. But fortunately, major players in the industry, such as McKesson, are pushing for change as well
Chemistry World June 10, 2014 Anthony King	Drug giants settle mismarketing lawsuits Pfizer and GlaxoSmithKline recently agreed to separate settlements over allegations of mismarketing drugs in the US.
Managed Care October 2004	AMA to Congress: Make Plans Respond Within 5 Minutes AMA delegates at the organization's annual meeting this year complained that doctors often have to wait more than 20 minutes to get an approval, often with the patient in the examining room.
The Motley Fool May 21, 2010 Brian Orelli	And You Thought Biotech Was High-Risk, High-Reward Large clinical trials make cardiovascular drugs risky, but the rewards are there, too.
The Motley Fool May 26, 2011 Brian Orelli	Congress Sets Bad Precedent With AVANIR What happened to free markets?
The Motley Fool July 28, 2010 Jordan DiPietro	3 Biotechs on Your Radar Screen It's not easy keeping track of all the drugs coming in and out of the development pipeline, but if you can stay up to date, you often have an advantage
The Motley Fool December 31, 2010 Brian Orelli	2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions.
Managed Care November 2002 Sharon Baker	Applause, Catcalls Greet Retainer Medicine Proponents tout personalized care and easy access, and imply superior health care. Critics fear "elitist" practices.
Reason November 2002 Jacob Sullum	Urine -- or You're Out Drug testing is invasive, insulting, and generally irrelevant to job performance. Why do so many companies insist on it?
The Motley Fool May 18, 2009 Brian Orelli	Free Drugs! Pfizer's giving over 70 drugs away -- to people who have lost their jobs and health insurance recently and can show financial hardship.
Chemistry World November 2010	Column: In the Pipeline Should drug companies focus on big markets and the blockbuster dream?
Science News July 18, 2009	Science Past From The Issue Of July 18, 1959 Suggestions were offered for using computerized information to help doctors diagnose illnesses.
Pharmaceutical Executive August 1, 2013 Jill Wechsler	Costs and Coverage Challenge Medicare Drug Plans Rate cuts and fraud concerns create problems for Part D plans and Part B providers.